RESUMEN
BACKGROUND: Eosinophilic gastritis (EG) is a clinicopathologic disorder with marked gastric eosinophilia and clinical symptoms. There is an unmet need among patients with EG for more precise diagnostic tools. OBJECTIVE: We aimed to develop tissue- and blood-based diagnostic platforms for EG. METHODS: Patients with EG and control subjects without EG were enrolled across 9 Consortium of Eosinophilic Gastrointestinal Disease Researchers-associated sites. An EG Diagnostic Panel (EGDP; gastric transcript subset) and EG blood biomarker panel (protein multiplex array) were analyzed. EGDP18 scores were derived from the expression of 18 highly dysregulated genes, and blood EG scores were derived from dysregulated cytokine/chemokine levels. RESULTS: Gastric biopsy specimens and blood samples from 185 subjects (patients with EG, n = 74; control subjects without EG, n = 111) were analyzed. The EGDP (1) identified patients with active EG (P < .0001, area under the curve ≥ 0.95), (2) effectively monitored disease activity in longitudinal samples (P = .0078), (3) highly correlated in same-patient samples (antrum vs body, r = 0.85, P < .0001), and (4) inversely correlated with gastric peak eosinophil levels (r = -0.83, P < .0001), periglandular circumferential collars (r = -0.73, P < .0001), and endoscopic nodularity (r = -0.45, P < .0001). For blood-based platforms, eotaxin-3, thymus and activation-regulated chemokine, IL-5, and thymic stromal lymphopoietin levels were significantly increased. Blood EG scores (1) distinguished patients with EG from control subjects without EG (P < .0001, area under the curve ≥ 0.91), (2) correlated with gastric eosinophil levels (plasma: r = 0.72, P = .0002; serum: r = 0.54, P = .0015), and (3) inversely correlated with EGDP18 scores (plasma: r = -0.64, P = .0015; serum: r = -0.46, P = .0084). Plasma eotaxin-3 levels strongly associated with gastric CCL26 expression (r = 0.81, P < .0001). CONCLUSION: We developed tissue- and blood-based platforms for assessment of EG and uncovered robust associations between specific gastric molecular profiles and histologic and endoscopic features, providing insight and clinical readiness tools for this emerging rare disease.
Asunto(s)
Citocinas , Endoscopía Gastrointestinal , Enteritis , Eosinofilia , Gastritis , Adolescente , Adulto , Biomarcadores/sangre , Niño , Citocinas/sangre , Citocinas/inmunología , Enteritis/sangre , Enteritis/diagnóstico , Enteritis/inmunología , Enteritis/patología , Eosinofilia/sangre , Eosinofilia/diagnóstico , Eosinofilia/inmunología , Eosinofilia/patología , Femenino , Gastritis/sangre , Gastritis/diagnóstico , Gastritis/inmunología , Gastritis/patología , Humanos , MasculinoRESUMEN
The effect of effective microorganisms (EM) on internal organ morphology, intestinal morphometry, and serum biochemical activity in Japanese quails under Clostridium perfringens challenge was determined. After 30 days of EM addition, one group of quails was orally inoculated with Clostridium perfringens. The second group did not receive EM and was inoculated with C. perfringens. In the gut, EM supplementation reduced the number of lesions, enhanced gut health, and protected the mucosa from pathogenic bacteria. EM showed an anti-inflammatory effect and fewer necrotic lesions in villi. In the internal organs, EM showed a protective effect against a typical lesion of C. perfringens infection. Necrosis and degeneration of the hepatocytes, necrosis of bile ducts, and bile duct proliferation were more severe in the infected group without EM. Morphometric evaluation showed significantly higher villi in the jejunum after EM addition. A greater crypt depth was observed in the C. perfringens group. Biochemical analysis of the blood indicated lower cholesterol on the 12th day of the experiment and between-group differences in total protein, lactate dehydrogenase (LDH), and albumin levels in the EM group. Further studies are needed to improve EM activity against pathologic bacteria as a potential alternative to antibiotics and to develop future natural production systems.
Asunto(s)
Antiinflamatorios/uso terapéutico , Enfermedades de las Aves/sangre , Enfermedades de las Aves/dietoterapia , Infecciones por Clostridium/sangre , Infecciones por Clostridium/dietoterapia , Clostridium perfringens , Enteritis/sangre , Enteritis/dietoterapia , Mucosa Intestinal/microbiología , Probióticos/uso terapéutico , Sustancias Protectoras/uso terapéutico , Codorniz/sangre , Codorniz/microbiología , Alimentación Animal/microbiología , Animales , Conductos Biliares/patología , Enfermedades de las Aves/microbiología , Colesterol/sangre , Infecciones por Clostridium/microbiología , Enteritis/microbiología , Femenino , Hepatocitos/patología , Mucosa Intestinal/patología , Yeyuno/microbiología , Yeyuno/patología , L-Lactato Deshidrogenasa/sangre , Necrosis , Albúmina Sérica/análisis , Resultado del TratamientoRESUMEN
OBJECTIVES: Lupus enteritis (LE) is a rare but well-known gastrointestinal manifestation of systemic lupus erythematosus (SLE). This study was conducted to identify prognostic factors associated with poor responses in patients with LE. METHODS: We consecutively registered patients diagnosed with LE between January 2009 and October 2019, and retrospectively compared their clinical characteristics based on whether they had good or poor responses to treatment. RESULTS: A total of 13 patients (17 episodes) were included. The median age was 41 years, and 12 patients were female. A comparison of clinical characteristics between groups revealed similar computed tomography (CT) findings. However, serum CH50 levels were significantly lower in the poor response group (median [interquartile ranges (IQR)]; 29.2 [25.3-46.9] U/mL vs 19.3 [7.8-24.0] U/mL, p = .0095). More patients in the poor response group had higher titers of anti-cardiolipin ß2-glycoprotein I antibody (anti-CL ß2GPI Ab) and were started on glucocorticoids (GCs) at moderate doses. In multivariable analysis, serum CH50 level was independently associated with poor response to induction therapy. CONCLUSION: Lower levels of CH50 at the time of initial treatment predicted inadequate treatment response in patients with LE.
Asunto(s)
Ensayo de Actividad Hemolítica de Complemento/normas , Enteritis/tratamiento farmacológico , Lupus Eritematoso Sistémico/tratamiento farmacológico , Adulto , Autoanticuerpos/inmunología , Enteritis/sangre , Enteritis/diagnóstico por imagen , Femenino , Glucocorticoides/administración & dosificación , Glucocorticoides/uso terapéutico , Humanos , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Tomografía Computarizada por Rayos X , beta 2 Glicoproteína I/inmunologíaRESUMEN
INTRODUCTION: Colorectal cancer (CRC) remains an incurable disease. Previous metabolomic studies show that metabolic signatures in plasma distinguish CRC patients from healthy controls. Chronic enteritis (CE) represents a risk factor for CRC, with a 20 fold greater incidence than in healthy individuals. However, no studies have performed metabolomic profiling to investigate CRC biomarkers in CE. OBJECTIVE: Our aims were to identify metabolomic signatures in CRC and CE and to search for blood-derived metabolite biomarkers distinguishing CRC from CE, especially early-stage biomarkers. METHODS: In this case-control study, 612 subjects were prospectively recruited between May 2015 and May 2016, and including 539 CRC patients (stage I, 102 cases; stage II, 259 cases; stage III, 178 cases) and 73 CE patients. Untargeted metabolomics was performed to identify CRC-related metabolic signatures in CE. RESULTS: Five pathways were significantly enriched based on 153 differential metabolites between CRC and CE. 16 biomarkers were identified for diagnosis of CRC from CE and for guiding CRC staging. The AUC value for CRC diagnosis in the external validation set was 0.85. Good diagnostic performances were also achieved for early-stage CRC (stage I and stage II), with an AUC value of 0.84. The biomarker panel could also stage CRC patients, with an AUC of 0.72 distinguishing stage I from stage II CRC and AUC of 0.74 distinguishing stage II from stage III CRC. CONCLUSIONS: The identified metabolic biomarkers exhibit promising properties for CRC monitoring in CE patients and are superior to commonly used clinical biomarkers (CEA and CA19-9).
Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias Colorrectales/metabolismo , Enteritis/metabolismo , Biomarcadores de Tumor/sangre , Estudios de Casos y Controles , Enfermedad Crónica , Neoplasias Colorrectales/sangre , Neoplasias Colorrectales/diagnóstico , Enteritis/sangre , Enteritis/diagnóstico , Femenino , Humanos , Masculino , Metabolómica , Persona de Mediana Edad , Estadificación de Neoplasias , FenotipoRESUMEN
PURPOSE: Beta-glucans are biologically active polysaccharides having antioxidant, immunomodulatory, and antiinflammatory properties. This study investigated the transcriptomic profile in peripheral blood of rats with LPS-induced enteritis, which were fed a diet supplemented with high- (G1) and low- (G2) molecular-weight oat beta-glucans. METHODS: Two-color rat gene expression microarrays were applied and the analysis was performed using a common reference design to provide easy means of comparing samples from various experimental conditions against one another. Common reference sample was labeled with cyanine 3 (Cy3) and investigated samples from each experimental group: C-G0 (control group fed semi-synthetic diet), LPS-G0 (LPS-challenged group fed semi-synthetic diet), LPS-G1 (LPS-challenged group fed G1 beta-glucan enriched diet), and LPS-G2 (LPS-challenged group fed G2 beta-glucan enriched diet) were labeled with cyanine 5 (Cy5). Each microarray was performed in quadruplicate. Statistical analysis was performed using one-way ANOVA and Tukey's HSD post-hoc test (p < 0.05). A multiple testing correction was performed using Benjamini and Hochberg False Discovery Rate < 5%. A quantitative real-time RT-PCR was performed to verify the expression of chosen transcripts. RESULTS: The microarray analyses revealed differentially expressed transcripts between: the LPS-G0 and the control groups: C-G0 (138 genes), the LPS-G1 and LPS-G0 groups (533 genes), and the LPS-G2 and LPS-G0 groups (97 genes). Several differentially expressed genes in the beta-glucan-supplemented groups encoded proteins belonging to TLR and NLR signaling pathways, as well as prostaglandin synthesis and regulation pathways. Both beta-glucans up-regulated the expression of Atg10, which belongs to the family of autophagy-related genes, suggesting a possible link between autophagy induction and beta-glucan supplementation. CONCLUSION: The changes in gene expression observed in the peripheral blood indicate that oat beta-glucans exerted a protective effect in rats with an induced inflammatory state caused by LPS challenge. The greater number of differentially expressed genes was observed in group supplemented with G1 beta-glucan, pointing at the differences in the mode of action of high- and low-molecular-weight beta-glucans in the organism.
Asunto(s)
Avena , Enteritis/inmunología , Regulación de la Expresión Génica/efectos de los fármacos , beta-Glucanos/farmacocinética , Administración Oral , Alimentación Animal , Animales , Modelos Animales de Enfermedad , Enteritis/sangre , Enteritis/dietoterapia , Regulación de la Expresión Génica/inmunología , Inmunidad , Lipopolisacáridos , Masculino , Peso Molecular , Ratas , Ratas Sprague-Dawley , beta-Glucanos/administración & dosificación , beta-Glucanos/sangreRESUMEN
Although the symptoms of systemic lupus erythematosus (SLE) worsen during pregnancy, few previous studies have reported lupus enteritis in pregnant women with SLE. A 29-year-old pregnant Japanese woman presented with acute abdomen. Six years before pain onset, she developed pure red cell aplasia and tested positive for anti-Ro (SS-A) and anti-La (SS-B) antibodies. Anti-DNA antibodies were detected two and a half years later. The patient remained asymptomatic until she developed acute abdomen. A mild increase in anti-DNA antibody levels and a mild decrease in complement levels were observed, and abdominal ultrasound and magnetic resonance imaging revealed the presence of large-volume ascites and edematous thickening of the small intestinal wall. These findings established the diagnosis of lupus enteritis. Her condition improved after treatment with prednisolone 50 mg/day, and she delivered a female infant weighing approximately 1810 g at 37 weeks of gestation. Our study suggests that lupus enteritis should be suspected in female patients with autoimmune disease who develop acute abdomen during pregnancy, and that magnetic resonance imaging is useful in its diagnosis.
Asunto(s)
Abdomen Agudo/sangre , Enteritis/sangre , Lupus Eritematoso Sistémico/sangre , Complicaciones del Embarazo/sangre , Abdomen Agudo/diagnóstico por imagen , Abdomen Agudo/tratamiento farmacológico , Adulto , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Anticuerpos Antinucleares/sangre , Enteritis/diagnóstico por imagen , Enteritis/tratamiento farmacológico , Femenino , Humanos , Lupus Eritematoso Sistémico/diagnóstico por imagen , Imagen por Resonancia Magnética , Prednisolona/administración & dosificación , Prednisolona/uso terapéutico , Embarazo , Complicaciones del Embarazo/diagnóstico por imagen , Complicaciones del Embarazo/tratamiento farmacológico , UltrasonografíaRESUMEN
This paper aims to compare and analyze clinical efficacy of azithromycin and pefloxacin in treatment of acute enteritis. The 160 patients with acute enteritis were randomly divided into a study group (n=80) treated with azithromycin, and a reference group (n=80) treated with pefloxacin. We compared overall treatment efficiency (markedly, effective, invalid), clinical symptoms and signs remission time (antipyretic time, antidiarrheal time, symptoms and signs disappearance time), interleukin-6 and C-reactive protein concentration before and after treatment, adverse reactions rate (nausea, abdominal pain, headache, etc.). In comparison of overall treatment efficiency of the two groups, the results showed that the study group was significantly superior to the reference group (P<0.05). In comparison of clinical symptoms and signs remission time of the two groups, the study group were significantly shorter than the reference group (P<0.05). At the same time, in comparison of levels of interleukin-6 and C-reactive protein concentration after treatment, the study group was significantly superior to the reference group (P<0.05). There was no significant difference between the two groups in incidence of adverse reactions (P<0.05). The efficacy of azithromycin for acute enteritis is better than that of pefloxacin, and it can significantly reduce clinical symptom remission time. Moreover, safe and reliable, it has great value in clinical application.
Asunto(s)
Azitromicina/uso terapéutico , Enteritis/tratamiento farmacológico , Pefloxacina/uso terapéutico , Adulto , Anciano , Antibacterianos/uso terapéutico , Azitromicina/efectos adversos , Proteína C-Reactiva/metabolismo , Enteritis/sangre , Enteritis/metabolismo , Femenino , Humanos , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Pefloxacina/efectos adversos , Factores de Tiempo , Adulto JovenRESUMEN
Acute necrotic pancreatitis was followed by disorders of intestinal functions in 96.7% of patients and in 68% its failure was occurred what had directly influenced on frequency of purulentseptic complication and mortality rate. It was proved that citrulline plasma level had been objectively reflected the severity of enteral failure and served as independent lethality criteria in patients with acute necrotic pancreatitis.
Asunto(s)
Citrulina/sangre , Enteritis/diagnóstico , Pancreatitis Aguda Necrotizante/diagnóstico , Peritonitis/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Enteritis/sangre , Enteritis/etiología , Enteritis/mortalidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Páncreas/metabolismo , Páncreas/patología , Pancreatitis Aguda Necrotizante/sangre , Pancreatitis Aguda Necrotizante/complicaciones , Pancreatitis Aguda Necrotizante/mortalidad , Peritonitis/sangre , Peritonitis/etiología , Peritonitis/mortalidad , Pronóstico , Análisis de SupervivenciaAsunto(s)
Dolor Abdominal/fisiopatología , Enteritis/fisiopatología , Eosinofilia/fisiopatología , Gastritis/fisiopatología , Mucosa Intestinal/patología , Náusea/fisiopatología , Dolor Abdominal/psicología , Adolescente , Adulto , Ansiedad/psicología , Niño , Depresión/psicología , Enteritis/sangre , Enteritis/patología , Enteritis/psicología , Eosinofilia/sangre , Eosinofilia/patología , Eosinofilia/psicología , Femenino , Gastritis/sangre , Gastritis/patología , Gastritis/psicología , Humanos , Hipersensibilidad , Masculino , Persona de Mediana Edad , Náusea/psicología , Triptasas/sangre , Adulto JovenRESUMEN
BACKGROUND: Chronic radiation enteritis (CRE) is defined as loss of absorptive capacity after irradiation due to chronic inflammation and damage of intestinal mucosa, which may lead to varying degrees of malnutrition. The aim of this study was to evaluate the potential correlation between the nutritional status and systemic inflammation in patients with CRE. METHODS: Medical records of 92 patients with CRE and 184 age- and sex-matched controls in a single center from January 2010 to October 2015 were retrospectively reviewed. All enrolled subjects underwent nutritional status analysis, including three different nutritional indices: Nutritional Risk Screening-2002 (NRS-2002), Patient-generated Subjective Global Assessment (PG-SGA) and Controlling Nutritional Status (CONUT), bioelectrical impedance spectroscopy (BIS), and biochemical markers, within 24 h of admission. RESULTS: The results showed that NRS-2002, PG-SGA and CONUT were all positively correlated with neutrophil/lymphocyte ratio (NLR) (r = 0.304, 0.384 and 0.425, all p < 0.001) and C-reactive protein (CRP) (r = 0.357, 0.479 and 0.230, all p < 0.001), while negatively correlated with albumin (r = -0.612, -0.727 and -0.792, all p < 0.001) and total cholesterol (TC) (r = -0.485, -0.545 and -0.473, all p < 0.001) in patients with CRE, respectively. Body cell mass (BCM) has been deemed a key body composition parameter. It was positively correlated with albumin (r = 0.489, p < 0.001) and TC (r = 0.237, p < 0.001), while negatively correlated with NLR (r = -0.140, p = 0.02) and CRP (r = -0.215, p < 0.001). A multivariate linear regression analysis showed that values of intracellular water (ß coefficient = 0.760, p < 0.001), extracellular water (ß coefficient = 0.006, p = 0.011), protein (ß coefficient = 0.235, p < 0.001) and CRP (ß coefficient = 0.001, p = 0.009) were independent determinants of BCM. CONCLUSION: This study revealed that BIS combined with nutritional assessments and biochemical markers were appropriate methods to assess the nutritional and inflammatory status in patients with CRE. Furthermore, the nutritional status was verified to be significantly correlated with systemic inflammation.
Asunto(s)
Biomarcadores/sangre , Composición Corporal , Enteritis/sangre , Desnutrición/sangre , Evaluación Nutricional , Radioterapia/efectos adversos , Adulto , Índice de Masa Corporal , Proteína C-Reactiva/metabolismo , Estudios de Casos y Controles , Colesterol/sangre , Enfermedad Crónica , Creatinina/sangre , Impedancia Eléctrica , Enteritis/complicaciones , Femenino , Humanos , Inflamación , Modelos Lineales , Linfocitos/citología , Masculino , Desnutrición/etiología , Persona de Mediana Edad , Análisis Multivariante , Neutrófilos/citología , Estado Nutricional , Estudios Retrospectivos , Factores de Riesgo , Albúmina Sérica/metabolismoRESUMEN
OBJECTIVES: To compare the clinical characteristics of lupus enteritis (LE) and non-enteric lupus (non-LE) patients and identify predictors of LE recurrence. METHODS: We retrospectively reviewed the medical records of 62 systemic lupus erythematosus (SLE) patients in a tertiary hospital who experienced enteric symptoms and underwent abdominal computed tomography scanning between January 1997 and December 2013. We compared the clinical characteristics between LE and non-LE patients and between recurrent LE and non-recurrent LE cases. RESULTS: Out of 62 SLE patients with enteric symptoms, 46 cases (74%) were compatible with LE based on computed tomography findings. The C4 level was decreased in the LE group compared with the non-LE group (9.0 ± 5.6 vs. 12.3 ± 6.2, p = 0.032). Recurrence of LE was observed in 14 patients (28%). Initial involvement at the colon (79% vs. 41%, p = 0.026) and bladder with/without the ureter was more common in the recurrent group (57% vs. 25%, p = 0.048). By multivariate analysis, the hazard ratios of variables associated with recurrence were 4.689 for colon involvement (95% confidence interval: 1.245-17.659, p = 0.0220] and 5.468 for cystitis with/without ureteritis (95% confidence interval: 1.629-18.360, p = 0.006). CONCLUSION: Colon and urinary tract involvement in LE patients may be associated with the recurrence of LE.
Asunto(s)
Enteritis/patología , Lupus Eritematoso Sistémico/patología , Adulto , Biomarcadores/sangre , Complemento C4/inmunología , Cistitis/sangre , Cistitis/tratamiento farmacológico , Cistitis/patología , Enteritis/sangre , Enteritis/tratamiento farmacológico , Femenino , Humanos , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Análisis Multivariante , Valor Predictivo de las Pruebas , Pronóstico , Recurrencia , Estudios Retrospectivos , Tomógrafos Computarizados por Rayos XRESUMEN
In this study, we investigated the prognostic factors of infantile rotavirus (RV) infection. A total of 102 infants with RV enteritis were divided into 2 groups according to the standards of improvement and cure at the time of discharge from the hospital: improvement group (N = 58; 47 males and 11 females with an average age of 15.19 ± 5.03 months) and the cure group (N = 44; 34 males and 10 females with an average age of 10.02 ± 4.92 months). Both groups were phlebotomized for the detection of serum glutamic oxaloacetic aminotransferase, creatine kinase-MB, and lactate dehydrogenase. Prognostic factors and clinical data were analyzed by univariate and multivariate logistic analysis. Among the 102 cases of RV infection, 58 were cured and 44 were improved. Univariate analysis showed that the 2 groups were significantly different in age, feeding pattern, concentrations of serum glutamic oxaloacetic aminotransferase, creatine kinase-MB, and lactate dehydrogenase, and central nervous system damage. Logistic regression analysis showed that age, feeding, and central nervous system damage were significant independent prognostic factors for RV enteritis (P < 0.05). There were no statistical differences in gender, course of disease, and respiratory infection (P < 0.05). Both myocardial and hepatic damages presented a temporary feature in the infants and had no significant influence on prognosis. Age, feeding pattern, and central nervous system damage are significant independent prognostic factors for RV infection. These factors should be carefully considered in clinical practice.
Asunto(s)
Aspartato Aminotransferasas/sangre , Enteritis/sangre , L-Lactato Deshidrogenasa/sangre , Infecciones por Rotavirus/sangre , Forma MB de la Creatina-Quinasa/sangre , Enteritis/genética , Enteritis/patología , Femenino , Humanos , Lactante , Masculino , Miocardio/patología , Pronóstico , Infecciones por Rotavirus/genética , Infecciones por Rotavirus/patologíaRESUMEN
BACKGROUND: The definition of eosinophilic gastritis (EG) is currently limited to histologic EG based on the tissue eosinophil count. OBJECTIVE: We aimed to provide additional fundamental information about the molecular, histopathologic, and clinical characteristics of EG. METHODS: Genome-wide transcript profiles and histologic features of gastric biopsy specimens, as well as blood eosinophil counts, were analyzed in patients with EG and control subjects (n = 15 each). RESULTS: The peak gastric antrum eosinophil count was 283 ± 164 eosinophils/×400 high-power field in patients with EG and 11 ± 9 eosinophils/×400 high-power field in control subjects (P = 6.1 × 10(-7)). Patients with EG (87%) had coexisting eosinophilic inflammation in multiple gastrointestinal segments; the esophagus represented the most common secondary site. Increased peripheral blood eosinophil counts (patients with EG: 1.09 ± 0.88 × 10(3)/µL vs control subjects: 0.09 ± 0.08 10(3)/µL, P = .0027) positively correlated with peak gastric eosinophil counts (Pearson r(2) = .8102, P < .0001). MIB-1(+) (proliferating), CD117(+) (mast cells), and FOXP3(+) (regulatory T cells, activated T cells, or both) cell counts were increased in patients with EG. Transcript profiling revealed changes in 8% of the genome in gastric tissue from patients with EG. Only 7% of this EG transcriptome overlapped with the eosinophilic esophagitis transcriptome. Significantly increased IL4, IL5, IL13, IL17, CCL26, and mast cell-specific transcripts and decreased IL33 transcripts were observed. CONCLUSION: EG is a systemic disorder involving profound blood and gastrointestinal tract eosinophilia, TH2 immunity, and a conserved gastric transcriptome markedly distinct from the eosinophilic esophagitis transcriptome. The data herein define germane cellular and molecular pathways of EG and provide a basis for improving diagnosis and treatment.
Asunto(s)
Citocinas/inmunología , Enteritis/inmunología , Eosinofilia/inmunología , Gastritis/inmunología , Estómago/inmunología , Células Th2/inmunología , Transcriptoma/inmunología , Adolescente , Adulto , Niño , Preescolar , Citocinas/biosíntesis , Enteritis/sangre , Enteritis/patología , Eosinofilia/sangre , Eosinofilia/patología , Eosinófilos/inmunología , Eosinófilos/metabolismo , Eosinófilos/patología , Femenino , Mucosa Gástrica/metabolismo , Gastritis/sangre , Gastritis/patología , Estudio de Asociación del Genoma Completo , Humanos , Lactante , Masculino , Estómago/patología , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Linfocitos T Reguladores/patología , Células Th2/metabolismo , Células Th2/patologíaRESUMEN
PURPOSE: Healthy ageing is associated with higher levels of glutathione. The study aimed to determine whether long-term dietary fortification with cysteine increases cysteine and glutathione pools, thus alleviating age-associated low-grade inflammation and resulting in global physiological benefits. METHODS: The effect of a 14-week dietary fortification with cysteine was studied in non-inflamed (NI, healthy at baseline) and in spontaneously age-related low-grade inflamed (LGI, prefrail at baseline) 21-month-old rats. Fifty-seven NI rats and 14 LGI rats received cysteine-supplemented diet (4.0 g/kg of free cysteine added to the standard diet containing 2.8 g/kg cysteine). Fifty-six NI rats and 16 LGI rats received a control alanine-supplemented diet. RESULTS: Cysteine fortification in NI rats increased free cysteine (P < 0.0001) and glutathione (P < 0.03) in the liver and the small intestine. In LGI rats, cysteine fortification increased total non-protein cysteine (P < 0.0007) and free cysteine (P < 0.03) in plasma, and free cysteine (P < 0.02) and glutathione (P < 0.01) in liver. Food intake decreased over time in alanine-fed rats (r² = 0.73, P = 0.0002), whereas it was constant in cysteine-fed rats (r² = 0.02, P = 0.68). Cysteine fortification did not affect inflammatory markers, mortality, body weight loss, or tissue masses. CONCLUSION: Doubling the dietary intake of cysteine in old rats increased cysteine and glutathione pools in selected tissues. Additionally, it alleviated the age-related decline in food intake. Further validation of these effects in the elderly population suffering from age-related anorexia would suggest a useful therapeutic approach to the problem.
Asunto(s)
Envejecimiento , Anorexia/prevención & control , Antioxidantes/uso terapéutico , Regulación del Apetito , Cisteína/uso terapéutico , Suplementos Dietéticos , Glutatión/metabolismo , Animales , Anorexia/sangre , Anorexia/inmunología , Anorexia/metabolismo , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/metabolismo , Antiinflamatorios no Esteroideos/uso terapéutico , Antioxidantes/efectos adversos , Antioxidantes/metabolismo , Cisteína/efectos adversos , Cisteína/sangre , Cisteína/metabolismo , Suplementos Dietéticos/efectos adversos , Ingestión de Energía , Enteritis/sangre , Enteritis/inmunología , Enteritis/metabolismo , Enteritis/prevención & control , Hepatitis/sangre , Hepatitis/inmunología , Hepatitis/metabolismo , Hepatitis/prevención & control , Homeostasis , Mediadores de Inflamación/sangre , Mediadores de Inflamación/metabolismo , Mucosa Intestinal/inmunología , Mucosa Intestinal/metabolismo , Intestino Delgado/inmunología , Intestino Delgado/metabolismo , Hígado/inmunología , Hígado/metabolismo , Masculino , Estrés Oxidativo , Ratas WistarRESUMEN
Gastrointestinal bleeding and iron deficiency anaemia may cause severe symptoms and may require extensive diagnostics and substantial amounts of health resources.This case report focuses on the clinical presentation of a 22 year old patient with recurrent gastrointestinal bleeding from multilocular non-healing ulcers of the stomach, duodenum and jejunum over a period of four years. Extensive gastroenterological and allergological standard diagnostic procedures showed benign ulcerative lesions with tissue eosinophilia, but no conclusive diagnosis. Multiple diagnostic procedures were performed, until finally, endoscopically guided segmental gut lavage identified locally produced, intestinal IgE antibodies by fluoro-enzyme-immunoassay.IgE antibody concentrations at the intestinal level were found to be more-fold increased for total IgE and food-specific IgE against nuts, rye flour, wheat flour, pork, beef and egg yolk compared with healthy controls.Thus, a diet eliminating these allergens was introduced along with antihistamines and administration of a hypoallergenic formula, which resulted in complete healing of the multilocular ulcers with resolution of gastrointestinal bleeding. All gastrointestinal lesions disappeared and total serum IgE levels dropped to normal within 9 months. The patient has been in remission now for more than two years.Eosinophilic gastroenteritis (EG) is well known to induce refractory ulcer disease. In this case, the mechanisms for intestinal damage and gastrointestinal bleeding were identified as local gastrointestinal type I allergy. Therefore, future diagnostics in EG should also be focused on the intestinal level as identification of causative food-specific IgE antibodies proved to be effective to induce remission in this patient.
Asunto(s)
Enteritis/diagnóstico , Eosinofilia/diagnóstico , Hipersensibilidad a los Alimentos/diagnóstico , Gastritis/diagnóstico , Hemorragia Gastrointestinal/diagnóstico , Úlcera/diagnóstico , Adulto , Anciano , Anemia Ferropénica/sangre , Animales , Bovinos , Yema de Huevo , Enteritis/sangre , Enteritis/complicaciones , Eosinofilia/sangre , Eosinofilia/complicaciones , Femenino , Harina , Hipersensibilidad a los Alimentos/complicaciones , Gastritis/sangre , Gastritis/complicaciones , Hemorragia Gastrointestinal/etiología , Tracto Gastrointestinal/patología , Voluntarios Sanos , Humanos , Inmunoglobulina E/sangre , Masculino , Carne , Persona de Mediana Edad , Nueces , Secale , Porcinos , Úlcera/complicaciones , Adulto JovenRESUMEN
The clinical and laboratory findings in puppies naturally infected with canine coronavirus (CCoV) and/or canine parvovirus (CPV) were compared with findings in uninfected puppies. Lymphopenia was the only parameter related to CCoV infection that was statistically significant; vomiting, anorexia, lethargy, hemorrhagic fluid diarrhea, leukopenia, lymphopenia, thrombocytopenia, hypoglycemia, and hypoproteinemia were correlated with CPV infection.
Résultats cliniques, hématologiques et biochimiques chez des chiots atteints de l'entérite à coronavirus et à parvovirus. Les résultats cliniques et de laboratoire chez des chiots naturellement infectés par le coronavirus canin (CoVC) et/ou le parvovirus canin (PVC) ont été comparés aux résultats des chiots non infectés. La lymphopénie était le seul paramètre statistiquement significatif associé à l'infection par le CoVC; les vomissements, l'anorexie, la léthargie, la diarrhée liquide hémorragique, la leucopénie, la lymphopénie, la thrombocytopénie, l'hypoglycémie et l'hypoprotéinémie étaient tous associés à l'infection par le PVC.(Traduit par Isabelle Vallières).
Asunto(s)
Infecciones por Coronavirus/veterinaria , Coronavirus Canino/aislamiento & purificación , Enfermedades de los Perros/virología , Enteritis/veterinaria , Infecciones por Parvoviridae/veterinaria , Parvovirus Canino/aislamiento & purificación , Animales , Coinfección , Infecciones por Coronavirus/sangre , Infecciones por Coronavirus/patología , Enfermedades de los Perros/sangre , Enfermedades de los Perros/patología , Perros , Enteritis/sangre , Enteritis/patología , Enteritis/virología , Infecciones por Parvoviridae/sangre , Infecciones por Parvoviridae/patologíaRESUMEN
BACKGROUND/AIM: The role of Th2-type cytokines in development of eosinophilic esophagitis (EoE) has been largely revealed, whereas research on the pathogenesis of eosinophilic gastroenteritis (EGE) has not been widely performed. We investigated the possible involvement of Th2-type cytokines in EGE by measuring plasma cytokine concentrations in patients with EGE as well as those with EoE. METHODS: 18 patients with EoE, 18 with EGE, and 30 normal volunteers were enrolled in the study. Plasma concentrations of five cytokines (thymic stromal lymphopoietin, IL-5, IL-13, IL-15, and eotaxin-3) were measured using Milliplex assays. Clinical characteristics of the patients and plasma cytokine levels were then compared. RESULTS: Higher proportions of patients with EoE and those with EGE showed elevated plasma concentrations of IL-5 and IL-15 as compared to the normal controls. There was also a positive correlation between IL-5 and IL-15, and also with blood eosinophil count. The plasma concentrations of these cytokines tended to be higher in cases with EGE than in those with EoE, though there were overlaps in cytokine levels among the patients and controls. CONCLUSION: Similar increases in plasma IL-5 and IL-15 were observed in patients with EoE and those with EGE.
Asunto(s)
Citocinas/sangre , Enteritis/sangre , Eosinofilia/sangre , Esofagitis Eosinofílica/sangre , Gastritis/sangre , Gastroenteritis/sangre , Biomarcadores/sangre , Enteritis/epidemiología , Eosinofilia/epidemiología , Esofagitis Eosinofílica/epidemiología , Femenino , Gastritis/epidemiología , Gastroenteritis/epidemiología , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad , PrevalenciaAsunto(s)
Citocinas/genética , Enteritis/genética , Eosinofilia/genética , Eosinófilos/inmunología , Gastritis/genética , Interleucina-33/genética , Estudios de Casos y Controles , Quimiocina CCL21/sangre , Quimiocina CCL21/genética , Quimiocina CCL21/inmunología , Quimiocina CCL27/sangre , Quimiocina CCL27/genética , Quimiocina CCL27/inmunología , Quimiocina CCL7/sangre , Quimiocina CCL7/genética , Quimiocina CCL7/inmunología , Citocinas/sangre , Citocinas/inmunología , Enteritis/sangre , Enteritis/inmunología , Enteritis/patología , Eosinofilia/sangre , Eosinofilia/inmunología , Eosinofilia/patología , Eosinófilos/patología , Femenino , Gastritis/sangre , Gastritis/inmunología , Gastritis/patología , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Humanos , Lactante , Interleucina-33/sangre , Interleucina-33/inmunología , Masculino , Linfopoyetina del Estroma TímicoRESUMEN
BACKGROUND: Eosinophilic gastrointestinal disorders (EGIDs) are disorders characterized by primary eosinophil inflammation in the gastrointestinal tract. There are a small number of reports of eosinophil infiltration in gastrointestinal tracts presenting as EGIDs in infants. In this study, we present Japanese cases of EGIDs in infants. METHODS: Five patients diagnosed with or strongly suspected to have EGIDs in our hospital from 2008 to 2010 were reviewed. Radiographic contrast enema examinations and/or endoscopies were performed in 4 and 3 patients, respectively. RESULTS: There were patients with eosinophilic colitis (1 suspected and 2 biopsy-proven), a patient who was suspected of having allergic eosinophilic enterocolitis, and a patient with eosinophilic gastroenteritis associated with pediatric hypereosinophilic syndrome. CONCLUSIONS: The causes and clinical findings of patients with intestinal eosinophil inflammation vary. Therefore, deliberate examination and observation are important for patients with infantile EGID.
Asunto(s)
Enteritis , Eosinofilia , Gastritis , Colon/patología , Anomalías Congénitas/patología , Constricción Patológica/patología , Eccema/complicaciones , Enteritis/sangre , Enteritis/complicaciones , Enteritis/diagnóstico , Enteritis/etiología , Enteritis/patología , Enteritis/terapia , Eosinofilia/sangre , Eosinofilia/complicaciones , Eosinofilia/diagnóstico , Eosinofilia/etiología , Eosinofilia/patología , Eosinofilia/terapia , Eosinófilos/patología , Heces/citología , Femenino , Mucosa Gástrica/patología , Gastritis/sangre , Gastritis/complicaciones , Gastritis/diagnóstico , Gastritis/etiología , Gastritis/patología , Gastritis/terapia , Humanos , Síndrome Hipereosinofílico/sangre , Síndrome Hipereosinofílico/complicaciones , Síndrome Hipereosinofílico/patología , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Lactante , Recién Nacido , Mucosa Intestinal/patología , Japón , Masculino , Hipersensibilidad a la Leche/complicaciones , Hipersensibilidad a la Leche/inmunología , Miocarditis/complicaciones , Sangre Oculta , Prednisolona/uso terapéutico , Recto/patología , SíndromeRESUMEN
OBJECTIVE: To evaluate the clinical manifestations, endoscopic, and radiological characteristics, histological features, and treatment of eosinophilic gastroenteritis in adult patients. METHODS: The clinical records of 34 patients diagnosed as eosinophilic gastroenteritis and eight patients who had abdominal symptoms and unexplained peripheral eosinophilia but no evidence of tissue eosinophilic infiltration were reviewed and analyzed. RESULTS: Thirteen patients had a history of asthma or allergic rhinitis, while 10 had an allergic history. Peripheral eosinophilia occurred in 83.3% of patients, IgE was elevated in half, and α2-macroglobulin was elevated in 92.8% of patients. The small intestine(82.4%)was the most common site involved. Erythema was the predominate feature seen on endoscopy. Radiographic study generally revealed thickening of the small intestinal wall. Eosinophilia generally involved the lamina propria of mucosa, but any layer of the gut could be affected, even in sites which had normal endoscopic or radiographic appearance. In all, 15.4% (6/39) of patients had Helicobacter pylori infection. Symptom remission within 1 week was found in 80% (20/25) of patients treated with steroids and in 58.8% (10/17) of patients treated with symptomatic treatment. In all, 85.7% (18/21) of patients had their eosinophil counts return to normal within 2 weeks in the steroid treatment group, but none (0/13) in the other group. CONCLUSION: Eosinophilic gastroenteritis may be more common than previously recognized. Multiple biopsies obtained from the both normal and abnormal appearing areas in the second part of the duodenum are highly recommended. Steroids are effective in relieving symptoms and improving eosinophilia.